11-Aug-2026
Download PDF
Orchid Pharma
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Limited reviewed financial result (standalone and consolidated) of the company for Quarter-1 ended on June 30 2026 and restated Audited (Standalone & Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2026 on account of scheme of Amalgamation coming into effect
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
